Parkinson's Disease Treatments Market - Global Outlook and Forecast 2021-2027

Code: RW00014584652
Market Monitor Global
Oct-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Parkinson's Disease Treatments in Global, including the following market information:
Global Parkinson's Disease Treatments Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Parkinson's Disease Treatments market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinson's Disease Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinson's Disease Treatments Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Parkinson's Disease Treatments Market Segment Percentages, By Type, 2020 (%)
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs

China Parkinson's Disease Treatments Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Parkinson's Disease Treatments Market Segment Percentages, By Application, 2020 (%)
Hospitals
Healthcare Institutes
Others

Global Parkinson's Disease Treatments Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Parkinson's Disease Treatments Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Parkinson's Disease Treatments Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Parkinson's Disease Treatments Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Parkinson's Disease Treatments Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson's Disease Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson's Disease Treatments Overall Market Size
2.1 Global Parkinson's Disease Treatments Market Size: 2021 VS 2027
2.2 Global Parkinson's Disease Treatments Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson's Disease Treatments Players in Global Market
3.2 Top Global Parkinson's Disease Treatments Companies Ranked by Revenue
3.3 Global Parkinson's Disease Treatments Revenue by Companies
3.4 Top 3 and Top 5 Parkinson's Disease Treatments Companies in Global Market, by Revenue in 2020
3.5 Global Companies Parkinson's Disease Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson's Disease Treatments Players in Global Market
3.6.1 List of Global Tier 1 Parkinson's Disease Treatments Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson's Disease Treatments Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson's Disease Treatments Market Size Markets, 2021 & 2027
4.1.2 Dopamine Agonists
4.1.3 Levodopa
4.1.4 Glutamate Antagonist
4.1.5 Apomorphine
4.1.6 COMT Inhibitors Anticholinergics
4.1.7 MAO-B Inhibitors
4.1.8 Other Drugs
4.2 By Type - Global Parkinson's Disease Treatments Revenue & Forecasts
4.2.1 By Type - Global Parkinson's Disease Treatments Revenue, 2016-2021
4.2.2 By Type - Global Parkinson's Disease Treatments Revenue, 2022-2027
4.2.3 By Type - Global Parkinson's Disease Treatments Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson's Disease Treatments Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Healthcare Institutes
5.1.4 Others
5.2 By Application - Global Parkinson's Disease Treatments Revenue & Forecasts
5.2.1 By Application - Global Parkinson's Disease Treatments Revenue, 2016-2021
5.2.2 By Application - Global Parkinson's Disease Treatments Revenue, 2022-2027
5.2.3 By Application - Global Parkinson's Disease Treatments Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Parkinson's Disease Treatments Market Size, 2021 & 2027
6.2 By Region - Global Parkinson's Disease Treatments Revenue & Forecasts
6.2.1 By Region - Global Parkinson's Disease Treatments Revenue, 2016-2021
6.2.2 By Region - Global Parkinson's Disease Treatments Revenue, 2022-2027
6.2.3 By Region - Global Parkinson's Disease Treatments Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Parkinson's Disease Treatments Revenue, 2016-2027
6.3.2 US Parkinson's Disease Treatments Market Size, 2016-2027
6.3.3 Canada Parkinson's Disease Treatments Market Size, 2016-2027
6.3.4 Mexico Parkinson's Disease Treatments Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Parkinson's Disease Treatments Revenue, 2016-2027
6.4.2 Germany Parkinson's Disease Treatments Market Size, 2016-2027
6.4.3 France Parkinson's Disease Treatments Market Size, 2016-2027
6.4.4 U.K. Parkinson's Disease Treatments Market Size, 2016-2027
6.4.5 Italy Parkinson's Disease Treatments Market Size, 2016-2027
6.4.6 Russia Parkinson's Disease Treatments Market Size, 2016-2027
6.4.7 Nordic Countries Parkinson's Disease Treatments Market Size, 2016-2027
6.4.8 Benelux Parkinson's Disease Treatments Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Parkinson's Disease Treatments Revenue, 2016-2027
6.5.2 China Parkinson's Disease Treatments Market Size, 2016-2027
6.5.3 Japan Parkinson's Disease Treatments Market Size, 2016-2027
6.5.4 South Korea Parkinson's Disease Treatments Market Size, 2016-2027
6.5.5 Southeast Asia Parkinson's Disease Treatments Market Size, 2016-2027
6.5.6 India Parkinson's Disease Treatments Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Parkinson's Disease Treatments Revenue, 2016-2027
6.6.2 Brazil Parkinson's Disease Treatments Market Size, 2016-2027
6.6.3 Argentina Parkinson's Disease Treatments Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson's Disease Treatments Revenue, 2016-2027
6.7.2 Turkey Parkinson's Disease Treatments Market Size, 2016-2027
6.7.3 Israel Parkinson's Disease Treatments Market Size, 2016-2027
6.7.4 Saudi Arabia Parkinson's Disease Treatments Market Size, 2016-2027
6.7.5 UAE Parkinson's Disease Treatments Market Size, 2016-2027
7 Players Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Parkinson's Disease Treatments Major Product Offerings
7.1.4 GSK Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Parkinson's Disease Treatments Major Product Offerings
7.2.4 Merck Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Parkinson's Disease Treatments Major Product Offerings
7.3.4 Novartis Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Parkinson's Disease Treatments Major Product Offerings
7.4.4 Teva Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.4.5 Teva Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Major Product Offerings
7.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim Key News
7.6 Impax
7.6.1 Impax Corporate Summary
7.6.2 Impax Business Overview
7.6.3 Impax Parkinson's Disease Treatments Major Product Offerings
7.6.4 Impax Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.6.5 Impax Key News
7.7 Abbvie
7.7.1 Abbvie Corporate Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Parkinson's Disease Treatments Major Product Offerings
7.4.4 Abbvie Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.7.5 Abbvie Key News
7.8 Bausch Health
7.8.1 Bausch Health Corporate Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Parkinson's Disease Treatments Major Product Offerings
7.8.4 Bausch Health Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.8.5 Bausch Health Key News
7.9 Lundbeck
7.9.1 Lundbeck Corporate Summary
7.9.2 Lundbeck Business Overview
7.9.3 Lundbeck Parkinson's Disease Treatments Major Product Offerings
7.9.4 Lundbeck Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.9.5 Lundbeck Key News
7.10 Sun Pharma
7.10.1 Sun Pharma Corporate Summary
7.10.2 Sun Pharma Business Overview
7.10.3 Sun Pharma Parkinson's Disease Treatments Major Product Offerings
7.10.4 Sun Pharma Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.10.5 Sun Pharma Key News
7.11 Wockhardt
7.11.1 Wockhardt Corporate Summary
7.11.2 Wockhardt Business Overview
7.11.3 Wockhardt Parkinson's Disease Treatments Major Product Offerings
7.11.4 Wockhardt Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.11.5 Wockhardt Key News
7.12 Acadia
7.12.1 Acadia Corporate Summary
7.12.2 Acadia Business Overview
7.12.3 Acadia Parkinson's Disease Treatments Major Product Offerings
7.12.4 Acadia Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.12.5 Acadia Key News
7.13 UCB
7.13.1 UCB Corporate Summary
7.13.2 UCB Business Overview
7.13.3 UCB Parkinson's Disease Treatments Major Product Offerings
7.13.4 UCB Parkinson's Disease Treatments Revenue in Global (2016-2021)
7.13.5 UCB Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Parkinson's Disease Treatments Market Opportunities & Trends in Global Market
Table 2. Parkinson's Disease Treatments Market Drivers in Global Market
Table 3. Parkinson's Disease Treatments Market Restraints in Global Market
Table 4. Key Players of Parkinson's Disease Treatments in Global Market
Table 5. Top Parkinson's Disease Treatments Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Parkinson's Disease Treatments Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Parkinson's Disease Treatments Revenue Share by Companies, 2016-2021
Table 8. Global Companies Parkinson's Disease Treatments Product Type
Table 9. List of Global Tier 1 Parkinson's Disease Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE